Self-reported quality of life, anxiety and depression in individuals with Ehlers-Danlos syndrome (EDS): a questionnaire study

BMC Musculoskeletal Disorders

Per Kristiansson²  Maritta Pigg¹  Carina Pettersson²  Britta Berglund² 

[1] Department of Immunology, Genetics and Pathology, Section of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden;Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden

关键词: Hypermobility;    Depression;    Anxiety;    Quality of life;    HADS;    SF-36;    Ehlers-Danlos syndrome;    Connective tissue;   

Others  :  1174847
DOI  :  10.1186/s12891-015-0549-7

 received in 2014-11-01, accepted in 2015-04-01,  发布年份 2015

【 摘 要 】

Background

Many individuals with Ehlers-Danlos Syndrome (EDS) are hypermobile, suffer from long term pain, and have complex health problems. Since these sometimes have no objective physical signs, individuals with EDS sometimes are referred for psychiatric evaluation. The aim was therefore to identify the level of anxiety and quality of life in a Swedish group of individuals with EDS.

Methods

A postal survey in 2008 was distributed to 365 members over 18 years of the Swedish National EDS Association and 250 with EDS diagnosis responded. Two questionnaires, the Hospital Anxiety and Depression Scale (HADS) and SF-36, were used. A Swedish population study was used to compare results from SF-36. Independent Student’s t-test was used to compare differences between groups, possible relationships were tested using Spearman’s correlation coefficient and the General Linear Model was used for regression analyses. Higher scores on HADS represent higher levels of anxiety and depression and higher scores on SF-36 represent higher quality of health.

Results

Of the respondents 74.8% scored high on anxiety and 22.4% scored high on depression on the HADS. Age, tiredness and back pain was independently associated with the HAD anxiety score in a multiple regression analysis, When comparing the SF-36 scores from the EDS group and a Swedish population group, the EDS group scored significantly lower, indicating lower health-related quality of health than the general population (p < 0.001).

Conclusions

In comparison with a Swedish population group, a lower health-related quality of life was found in the EDS group. Also, higher levels of anxiety and depression were detected in individuals with EDS. The importance to explore the factors behind these results and what initiatives can be taken to alleviate the situation for this group is emphasized.

【 授权许可】

   
2015 Berglund et al.; licensee BioMed Central.

【 参考文献 】

• [1]Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ: Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998, 77:31-7.
• [2]Steinmann B, Royce PM, Superti-Furga A: The Ehlers-Danlos syndrome. In Connective tissue and its heritable disorders: molecular, genetic and medical aspects. Edited by Steinmann B, Royce PM. Wiley Liss, New York; 1993:351-407.
• [3]Berglund B, Nordström G: Symptoms and functional health status of individuals with Ehlers-Danlos syndrome (EDS). J Clin Rheumatol 2001, 7:308-14.
• [4]Maeland S, Assmus J, Berglund B: Subjective health complaints in individuals with Ehlers-Danlos syndrome: a questionnaire study. Int J Nurs Stud 2011, 48:720-4.
• [5]Berglund B, Björck E: Women with Ehlers-Danlos syndrome (EDS) experience low oral health-related quality of life. J Orofac Pain 2012, 26(4):307-14.
• [6]Bulbena A, Gago J, Sperry L, Berge D: The relationship between frequency and intensity of fears and a collagen condition. Depress Anxiety 2006, 23:412-7.
• [7]Bulbena A, Gago J, Pailhez G, Sperry L, Fullana MA, Vilarroya O: Joint hypermobility syndrome is a risk factor trait for anxiety disorders: a 15-year follow-up cohort study. Gen Hosp Psychiatry 2011, 33:363-70.
• [8]Smith TO, Easton V, Bacon H, Jerman E, Armon K, Poland F, et al.: The relationship between benign jointhypermobility syndrome and psychological distress: a systematic review and meta-analysis. Rheumatology (Oxford) 2014, 53(1):114-22.
• [9]Lumley MA, Jordan M, Rubenstein R, Tsipouras P, Evans MI: Psychosocial functioning in the Ehlers-Danlos syndrome. Am J Med Genet 1994, 53:149-52.
• [10]Berglund B, Mattiasson AC, Randers I: Dignity not fully upheld when seeking health care: experiences expressed by individuals suffering from Ehlers-Danlos syndrome. Disabil Rehabil 2010, 32(1):1-7.
• [11]Ware JE, Kosinski M: Interpreting SF-36 Summary Health Measure: a response. Q Life Res 2001, 10:405-13.
• [12]Sullivan M, Karlsson J, Ware JE Jr: The Swedish SF-36 Health Survey–I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995, 41:1349-58.
• [13]Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-70.
• [14]Bjelland I, Dahl AA, Tangen Haug T, Neckelmann D: The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Psychosom Res 2002, 52:69-77.
• [15]Vincent A, Benzo RP, Whipple MO, McAllister SJ, Erwin PJ, Saligan LN: Beyond pain in fibromyalgia: insights into the symptom of fatigue. Arthritis Research & Therapy 2013, 15:221. BioMed Central Full Text
• [16]Loge JH, Kaasa S: Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med 1998, 26(4):250-8.
• [17]Berglund B: Food hypersensitivity in individuals with EDS: a common problem. Nordic Journal of Nursing Research (accepted 2014).